GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Pretax Margin %

Glycorex Transplantation AB (NGM:GTAB B) Pretax Margin % : -17.10% (As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Glycorex Transplantation AB Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Glycorex Transplantation AB's Pre-Tax Income for the three months ended in Mar. 2025 was kr-1.66 Mil. Glycorex Transplantation AB's Revenue for the three months ended in Mar. 2025 was kr9.68 Mil. Therefore, Glycorex Transplantation AB's pretax margin for the quarter that ended in Mar. 2025 was -17.10%.

The historical rank and industry rank for Glycorex Transplantation AB's Pretax Margin % or its related term are showing as below:

NGM:GTAB B' s Pretax Margin % Range Over the Past 10 Years
Min: -101.34   Med: -26.7   Max: 19.04
Current: -24.87


NGM:GTAB B's Pretax Margin % is ranked better than
63.43% of 979 companies
in the Biotechnology industry
Industry Median: -111.27 vs NGM:GTAB B: -24.87

Glycorex Transplantation AB Pretax Margin % Historical Data

The historical data trend for Glycorex Transplantation AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glycorex Transplantation AB Pretax Margin % Chart

Glycorex Transplantation AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -29.81 -43.40 -23.59 -101.34 -31.29

Glycorex Transplantation AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -43.52 -24.30 -42.78 -19.82 -17.10

Competitive Comparison of Glycorex Transplantation AB's Pretax Margin %

For the Biotechnology subindustry, Glycorex Transplantation AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glycorex Transplantation AB's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glycorex Transplantation AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Glycorex Transplantation AB's Pretax Margin % falls into.


;
;

Glycorex Transplantation AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Glycorex Transplantation AB's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-11.002/35.159
=-31.29 %

Glycorex Transplantation AB's Pretax Margin for the quarter that ended in Mar. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-1.655/9.681
=-17.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glycorex Transplantation AB  (NGM:GTAB B) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Glycorex Transplantation AB Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Glycorex Transplantation AB's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Glycorex Transplantation AB Business Description

Traded in Other Exchanges
Address
Solvegatan 41, Lund, SWE, 223 70
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Glycorex Transplantation AB Headlines

No Headlines